Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma

Creative Commons License

BOSTANCI S., KOÇYİĞİT P., Vural S., HEPER A., Botsali A.

DERMATOLOGIC SURGERY, cilt.44, sa.1, ss.36-41, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 44 Sayı: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1097/dss.0000000000001266
  • Dergi Adı: DERMATOLOGIC SURGERY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.36-41
  • Ankara Üniversitesi Adresli: Evet

Özet

BACKGROUND Imiquimod 5% topical cream is approved for treatment of superficial basal cell carcinoma (BCC). Data on the long-term efficacy and usage in other BCC subtypes are scarce.